159
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Immobilized transferrin Fe3O4@SiO2 nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery

&
Pages 4631-4639 | Published online: 03 Dec 2013

References

  • MinottiGMennaPSalvatorelliECairoGGianniLAnthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicityPharmacol Rev200456218522915169927
  • PollakisGGoormaghtighERuysschaertJMRole of the quinine structure in the mitochondrial damage induced by antitumor anthracyclines. Comparison of adriamycin and 5-iminodaunorubicinFEBS Lett198315522672726852236
  • SingalPKIliskovicNDoxorubicin-induced cardiomyopathyN Engl J Med1998339139009059744975
  • SingalPKIliskovicNLiTKumarDAdriamycin cardiomyopathy: pathophysiology and preventionFASEB J199711129319369337145
  • KongSDZhangWZLeeJHMagnetically vectored nanocapsules for tumor penetration and remotely switchable on-demand drug releaseNano Lett20101050885092
  • OlariuCIYiuHHPBouffierLMultifunctional Fe3O4 nanoparticles for targeted bi-modal imaging of pancreatic cancerJ Mater Chem2011211265012659
  • ArrueboMFernández-PachecoRIbarraMRSantamaríaJMagnetic nanoparticles for drug deliveryNano today2007232232
  • AlexiouCArnoldWKleinRJLocoregional cancer treatment with magnetic drug targetingCancer Res200060236641664811118047
  • BabincovaMAltanerovaVAltanerCCicmanecPBabinecPIn vivo heating of magnetic nanoparticles in alternating magnetic fieldMed Phys20043182219222115377087
  • BruléSLevyMWilhelmCDoxorubicin release triggered by alginate embedded magnetic nanoheaters: a combined therapyAdv Mater201123678779021287643
  • MikhaylovGMikacUMagaevaAAFerri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironmentNat Nanotechnol20116959460221822252
  • GaihreBKhilbMSLeeDRKimHYGelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release studyInt J Pharm20093651–218018918790029
  • YuJMXieXZhengMFabrication and characterization of nuclear localization signal-conjugated glycol chitosan micelles for improving the nuclear delivery of doxorubicinInt J Nanomedicine201275079509023049255
  • El-GamelNEWortmannLArroubKMathurSSiO2@Fe2O3 core-shell nanoparticles for covalent immobilization and release of sparfloxacin drugChem Commun (Camb)2011476100761007821829847
  • AllenTMCullisPRDrug delivery systems: entering the nainstreamScience200430356651818182215031496
  • PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
  • PearceTRShroffKKokkoliEPeptide targeted lipid nanoparticles for anticancer drug deliveryAdv Mater2012242838033822371022674563
  • ParkJWHongKKirpotinDBAnti-HER2 immunoliposomes: enhanced efficacy attributable to targeted deliveryClin Cancer Res2002841172118111948130
  • YuMKParkJJeongYYMoonWKJonSIntegrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug deliveryNanotechnology2010214141510220852354
  • ToublanFJJBoppartSSuslickKSTumor targeting by surface-modified protein microspheresJ Am Chem Soc2006128113472347316536492
  • Indira ChandranVMatesicLLockeJMSkropetaDRansonMVineKLAnti-cancer activity of an acid-labile N-alkylisatin conjugate targeting the transferrin receptorCancer Lett2012316215115622115965
  • DanielsTRDelgadoTRodriguezJAHelgueraGPenichetMLThe transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancerClin Immunol2006121214415816904380
  • DanielsTRDelgadoTHelgueraGPenichetMLThe transferrin receptor part II: targeted delivery of therapeutic agents into cancer cellsClin Immunol2006121215917616920030
  • PengJLWuSZhaoXPDownregulation of transferrin receptor surface expression by intracellular antibodyBiochem Biophys Res Commun2007354486487117266924
  • KangYSRisbudSRaboltJFStroevePSynthesis and characterization of nanometer-size Fe3O4 and γ-Fe2O3 particlesChem Mater19968922092211
  • LiuXMaZXingJLiuHPreparation and characterization of amino-silane modified superparamagnetic silica nanospheresJ Magn Magn Mater20042701–216
  • GuoLHuangJZhangXLiYZhengLBacterial magnetic nanoparticle as a drug carrierJ Mater Chem20081859935997
  • BlissCThe calculation of the dose-mortality curveAnn Appl Biol193522134167
  • CiofaniGDel TurcoSGenchiGGD’AlessandroDBastaGMattoliVTransferrin-conjugated boron nitride nanotubes: protein grafting, characterization, and interaction with human endothelial cellsInt J Pharm20124361–244445322732669
  • DuWXuZNystromAMZhangKLeonardJRWooleyKL19F- and fluorescently labeled micelles as nanoscopic assemblies for chemotherapeutic deliveryBioconjug Chem200819122492249819049473
  • GuoSLiDZhangLLiJWangEMonodisperse mesoporous super-paramagnetic single-crystal magnetite nanoparticles for drug deliveryBiomaterials20093011881188919135248
  • HuYXieJTongYWWangCHEffect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cellsJ Control Release2007118171717241684
  • MezaMaryChapter 22: Application of magnetic particles in immunoassaysHafeliUSchuttWZborowskiMScientific and Clinical Applications of Magnetic CarriersNew YorkPlenum1997303310
  • XuXDengCGaoMYuWYangPZhangXSynthesis of magnetic microspheres with immobilized metal ions for enrichment and direct determination of phosphopeptides by matrix-assisted laser desorption ionization mass spectrometryAdv Mater2006182432893293
  • SahuSKMaitiSPramanikAGhoshSKPramanikPControlling the thickness of polymeric shell on magnetic nanoparticles loaded with doxorubicin for targeted delivery and MRI contrast agentCarbohydr Polym201287425932604